Jim Simons Genetron Holdings LTD Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.77 - $0.97 $308 - $388	-400 Reduced 0.26%	152,100 $124,000
Q2 2023 Aug 11, 2023	SELL	$0.87 - $1.04 $5,568 - $6,656	-6,400 Reduced 4.03%	152,500 $142,000
Q1 2023 May 12, 2023	SELL	$0.91 - $1.23 $182 - $246	-200 Reduced 0.13%	158,900 $167,000
Q4 2022 Feb 13, 2023	BUY	$0.8 - $1.12 $1,680 - $2,352	2,100 Added 1.34%	159,100 $178,000
Q3 2022 Nov 14, 2022	BUY	$0.91 - $1.69 $3,394 - $6,303	3,730 Added 2.43%	157,000 $123,000
Q2 2022 Aug 12, 2022	BUY	$1.28 - $2.4 $30,681 - $57,528	23,970 Added 18.54%	153,270 $261,000
Q1 2022 May 13, 2022	BUY	$2.19 - $6.09 $148,291 - $412,372	67,713 Added 109.95%	129,300 $283,000
Q4 2021 Feb 11, 2022	BUY	$5.81 - $14.39 $357,820 - $886,236	61,587 New	61,587 $376,000
Q3 2021 Nov 12, 2021	SELL	$11.55 - $20.3 $919,380 - $1.62 Million	-79,600 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.9 - $23.29 $1.42 Million - $1.85 Million	79,600 New	79,600 $1.6 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.